Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Predicting vaccine effectiveness against severe COVID-19 over time and against variants: a meta-analysis
Deborah Cromer, Megan Steain, Arnold Reynaldi, et al.
Nature Communications (2023) Vol. 14, Iss. 1
Open Access | Times Cited: 78

Showing 1-25 of 78 citing articles:

Evolution and neutralization escape of the SARS-CoV-2 BA.2.86 subvariant
Khadija Khan, Gila Lustig, Cornelius Römer, et al.
Nature Communications (2023) Vol. 14, Iss. 1
Open Access | Times Cited: 70
Prior vaccination promotes early activation of memory T cells and enhances immune responses during SARS-CoV-2 breakthrough infection
Mark M. Painter, Timothy S. Johnston, Kendall A. Lundgreen, et al.
Nature Immunology (2023) Vol. 24, Iss. 10, pp. 1711-1724
Open Access | Times Cited: 69
Antibody-independent protection against heterologous SARS-CoV-2 challenge conferred by prior infection or vaccination
Valeria Fumagalli, Micol Ravà, Davide Marotta, et al.
Nature Immunology (2024) Vol. 25, Iss. 4, pp. 633-643
Open Access | Times Cited: 24
Case fatality rates of COVID‐19 during epidemic periods of variants of concern: A meta-analysis by continents
Qianhang Xia, Yujie Yang, Fengling Wang, et al.
International Journal of Infectious Diseases (2024) Vol. 141, pp. 106950-106950
Open Access | Times Cited: 14
Monoclonal antibody levels and protection from COVID-19
Eva Stadler, Martin Burgess, Timothy E. Schlub, et al.
Nature Communications (2023) Vol. 14, Iss. 1
Open Access | Times Cited: 31
Original COVID-19 priming regimen impacts the immunogenicity of bivalent BA.1 and BA.5 boosters
Luca M. Zaeck, Ngoc H. Tan, Wim J. R. Rietdijk, et al.
Nature Communications (2024) Vol. 15, Iss. 1
Open Access | Times Cited: 8
Relationship between HLA genetic variations, COVID-19 vaccine antibody response, and risk of breakthrough outcomes
Junqing Xie, Beatriz Mothe, Marta Alcalde Herraiz, et al.
Nature Communications (2024) Vol. 15, Iss. 1
Open Access | Times Cited: 7
Modelling the impact of the Omicron BA.5 subvariant in New Zealand
Audrey Lustig, Giorgia Vattiato, Oliver J. Maclaren, et al.
Journal of The Royal Society Interface (2023) Vol. 20, Iss. 199
Open Access | Times Cited: 16
Comparison of Phenotypes of Headaches After COVID-19 Vaccinations Differentiated According to the Vaccine Used
Carl Göbel, Axel Heinze, Katja Heinze‐Kuhn, et al.
Vaccines (2025) Vol. 13, Iss. 2, pp. 113-113
Open Access
T cell-mediated protection in absence of virus neutralizing antibodies
Yeranddy A. Alpízar, Kai Dallmeier
Nature Microbiology (2025)
Closed Access
SARS-CoV-2 infection rates and associated risk factors in healthcare workers: systematic review and meta-analysis
Amit Bansal, Mai-Chi Trieu, Emily M. Eriksson, et al.
Scientific Reports (2025) Vol. 15, Iss. 1
Open Access
SARS-CoV-2 neutralizing antibody determination after vaccination using spectrophotometric measurement of lateral flow immunochromatography
Jianglei Ma, Scott Kaniper, Yuliya Vabishchevich, et al.
Scientific Reports (2025) Vol. 15, Iss. 1
Open Access
A humanised ACE2, TMPRSS2, and FCGRT mouse model reveals the protective efficacy of anti-receptor binding domain antibodies elicited by SARS-CoV-2 hybrid immunity
Fernanda Ana‐Sosa‐Batiz, Shailendra Kumar Verma, Norazizah Shafee, et al.
EBioMedicine (2025) Vol. 113, pp. 105619-105619
Open Access
Longitudinal analysis of antibody titers after primary and booster mRNA COVID-19 vaccination can identify individuals at risk for breakthrough infection
Hyeongki Park, Naotoshi Nakamura, Shô Miyamoto, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2025)
Open Access
COVID-19 vaccine effectiveness and evolving variants: understanding the immunological footprint
Luca M. Zaeck, Corine H. GeurtsvanKessel, Rory D. de Vries
The Lancet Respiratory Medicine (2023) Vol. 11, Iss. 5, pp. 395-396
Open Access | Times Cited: 12
Discovery of highly potent covalent SARS-CoV-2 3CLpro inhibitors bearing 2-sulfoxyl-1,3,4-oxadiazole scaffold for combating COVID-19
Fu-Mao Zhang, Ting Huang, Feng Wang, et al.
European Journal of Medicinal Chemistry (2023) Vol. 260, pp. 115721-115721
Closed Access | Times Cited: 12
Ursodeoxycholic acid does not affect the clinical outcome of SARS‐CoV‐2 infection: A retrospective study of propensity score‐matched cohorts
Giuseppe Marrone, Marcello Covino, Giuseppe Merra, et al.
Liver International (2023) Vol. 44, Iss. 1, pp. 83-92
Open Access | Times Cited: 12
Australia’s COVID-19 vaccine journey: progress and future perspectives
James A. Triccas, Megan Steain
Microbiology Australia (2024)
Open Access | Times Cited: 4
Predicting Vaccine Effectiveness for Hospitalization and Symptomatic Disease for Novel SARS-CoV-2 Variants Using Neutralizing Antibody Titers
Billy J. Gardner, A. Marm Kilpatrick
Viruses (2024) Vol. 16, Iss. 3, pp. 479-479
Open Access | Times Cited: 4
Immunogenicity of COVID-19 booster vaccination in IEI patients and their one year clinical follow-up after start of the COVID-19 vaccination program
Leanne P. M. van Leeuwen, Marloes Grobben, Corine H. GeurtsvanKessel, et al.
Frontiers in Immunology (2024) Vol. 15
Open Access | Times Cited: 4
Likelihood of Post-COVID Condition in people with hybrid immunity; data from the German National Cohort (NAKO);
Rafael Mikolajczyk, Sophie Diexer, Bianca Klee, et al.
Journal of Infection (2024) Vol. 89, Iss. 2, pp. 106206-106206
Closed Access | Times Cited: 4
The Asymptomatic Proportion of SARS‐CoV‐2 Omicron Variant Infections in Households: A Systematic Review
Nancy D. J. Shi, Adrian J. Marcato, Violeta Spirkoska, et al.
Influenza and Other Respiratory Viruses (2024) Vol. 18, Iss. 7
Open Access | Times Cited: 4
Inference of epidemic dynamics in the COVID-19 era and beyond
Anne Cori, Adam J. Kucharski
Epidemics (2024) Vol. 48, pp. 100784-100784
Open Access | Times Cited: 4
Regional geographies and public health lessons of the COVID-19 pandemic in the Arctic
Sweta Tiwari, Andrey N. Petrov, Nikolay Golosov, et al.
Frontiers in Public Health (2024) Vol. 11
Open Access | Times Cited: 3
The impact of Covid-19 vaccination in Aotearoa New Zealand: A modelling study
Samik Datta, Giorgia Vattiato, Oliver J. Maclaren, et al.
Vaccine (2024) Vol. 42, Iss. 6, pp. 1383-1391
Open Access | Times Cited: 3
Page 1 - Next Page

Scroll to top